- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
4 result(s) found for: Detergent.
Displaying page 1 of 1.
EudraCT Number: 2013-003733-15 | Sponsor Protocol Number: B-003 | Start Date*: 2013-11-13 |
Sponsor Name:VU University medical center | ||
Full Title: The Dutch CSF and PET Biomarker Concordance of Alzheimer’s Disease pathology study | ||
Medical condition: Patients visiting the VUmc Alzheimer Center with objective cognitive complaints or diagnosed with Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001678-34 | Sponsor Protocol Number: wa+tr_1 | Start Date*: 2008-08-20 | |||||||||||
Sponsor Name:Department of dermatology, Odense University Hospital | |||||||||||||
Full Title: Examination of the efficacy of glycerol, two topical steroids and a topical immune modulator in experimentally induced skin irritation | |||||||||||||
Medical condition: Irritative contact dermatitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005535-40 | Sponsor Protocol Number: 3599-001 | Start Date*: 2016-07-21 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 s-apr) Compared to DuraSeal Dural Sealant as an Adjunct ... | |||||||||||||
Medical condition: Intra-operative CSF leak | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000858-18 | Sponsor Protocol Number: 281102 | Start Date*: 2017-09-12 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A phase 3, prospective, randomized, controlled, open-label, multicenter, 2-period crossover study with a single arm continuation evaluating the safety and efficacy of BAX 930 (rADAMTS13) in the pro... | |||||||||||||
Medical condition: severe congenital thrombotic thrombocytopenic purpura (cTTP, Upshaw-Schulman Syndrome [USS], hereditary thrombotic thrombocytopenic purpura [hTTP]) | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Temporarily Halted) AT (Completed) FR (Ongoing) IT (Temporarily Halted) PL (Ongoing) Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.